Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €7.91B | 28.6x | 0.2 | €8.98 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.1% Upside | Upgrade to Pro+ | |
Grifols | Madrid | Healthcare | Pharmaceuticals | €7.91B | 28.6x | 0.2 | €12.61 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
Almirall | Madrid | Healthcare | Pharmaceuticals | €2.24B | 103.5x | 0.65 | €10.42 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €1.37B | 53.3x | €77.80 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.1% Upside | Upgrade to Pro+ | ||
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.31B | 12.5x | 1.56 | €4.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Clinica Baviera | Madrid | Healthcare | Healthcare Providers & Services | €712.98M | 18.3x | 10.15 | €43.80 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Natac Natural Ingredients | Madrid | Healthcare | Pharmaceuticals | €381.97M | 771.7x | -10.24 | €0.89 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.3% Downside | Upgrade to Pro+ | |
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €242.51M | 22.9x | €2.98 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Atrys Health | Madrid | Healthcare | Healthcare Providers & Services | €215.61M | -6.8x | -0.22 | €2.82 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oryzon Genomics | Madrid | Healthcare | Biotechnology & Medical Research | €203.08M | -40.7x | -4.66 | €2.62 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prim | Madrid | Healthcare | Healthcare Equipment & Supplies | €201.61M | 18.6x | -1.4 | €11.95 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.2% Upside | Upgrade to Pro+ | |
Pangaea Oncology | Madrid | Healthcare | Biotechnology & Medical Research | €59.09M | -10x | €1.72 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €27.46M | €3.92 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -38.5% Downside | Upgrade to Pro+ | |||
Biotechnology Assets | Madrid | Healthcare | Biotechnology & Medical Research | €24.89M | -8.2x | 0.03 | €0.36 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Substrate Artificial Inteligence | Madrid | Healthcare | Healthcare Equipment & Supplies | €13.95M | 1.3x | 0.02 | €0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Euroespes S.A. | Madrid | Healthcare | Healthcare Providers & Services | €3.91M | €0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |